Connect with us

Technology

Riverside Partners Rebrands as RS2 Healthcare Partners; Closes Continuation Vehicle for Loftware

Published

on

Rebrand reflects strategic decision to focus exclusively on healthcare investing

Craig Stern appointed Co-Managing Partner of RS2 Healthcare Partners alongside David Belluck

AKKR Strategic Capital served as lead investor in Loftware Continuation Vehicle in a transaction that provides additional committed funding to support Loftware’s future growth and enables new platform investments

BOSTON, May 11, 2026 /PRNewswire/ — Riverside Partners, a private equity firm headquartered in Boston, is pleased to announce its rebrand to RS2 Healthcare Partners (the “Firm”), reflecting the Firm’s exclusive focus going forward on healthcare investing in the lower middle market. The new brand underscores the Firm’s longstanding and deepening commitment to investing in pharma services, medical device contract manufacturing, technology-enabled healthcare, and other high-growth healthcare subsectors.

RS2 Healthcare Partners builds on over 30 years of experience and formalizes the strategic decision to exclusively pursue investments with a healthcare orientation going forward. RS2 Healthcare Partners’ specialized strategy is supported by a highly experienced team of investment professionals alongside Healthcare, Clinical, and AI Advisory Boards comprising over 30 executives, clinicians, and technology experts from leading healthcare organizations.

David Belluck, Co-Managing Partner at RS2 Healthcare Partners, said, “RS2 Healthcare Partners reflects the investment strategy and sector specialization we have cultivated over three decades of focused lower middle market healthcare investing. Our dedicated healthcare platform — anchored by established industry relationships, an experienced investment team, and veteran Advisory Boards — creates a differentiated ability to partner with founders and management teams to build market-leading businesses. The rebrand reinforces our commitment to being the partner of choice to founders and management teams in the lower middle market and marks an important milestone in the evolution of our firm.”

The Firm also announced the appointment of Craig Stern as Co-Managing Partner, joining David Belluck in leading RS2 Healthcare Partners. Having worked alongside Mr. Belluck for 14 years with an exclusive focus on healthcare investing, Mr. Stern’s new role reflects both the depth of their partnership and the Firm’s dedication to building a world-class healthcare-focused investment platform.

Mr. Belluck added, “I am pleased to announce Craig Stern’s appointment as Co-Managing Partner of RS2 Healthcare Partners. Craig and I have worked side by side to build our healthcare investment platform, and his elevated role is a natural next step that is a testament to both the strength of our partnership and our shared commitment to the Firm’s continued growth.”

“We have been focused on creating a firm with a differentiated approach to healthcare investing, grounded in extensive sector expertise, a collaborative and values-driven culture, and trusted partnerships with founders and management teams,” said Craig Stern, Co-Managing Partner at RS2 Healthcare Partners. “We have deep conviction and a shared vision for the opportunity ahead and I am excited to co-lead the Firm going forward with David as we build on the strong foundation already in place.”

RS2 Healthcare Partners also completed a single-asset continuation vehicle (the “Continuation Vehicle”) for Loftware, Inc. (“Loftware” or the “Company”), a leading global enterprise labeling and artwork management provider of cloud-based software solutions. The transaction highlights the Firm’s healthcare expertise, as evidenced by Loftware’s life sciences vertical growing from a nascent business into Loftware’s largest and fastest-growing end-market and a key area for future growth. Accel-KKR’s (“AKKR”) dedicated secondary fund, AKKR Strategic Capital, served as lead investor of the Continuation Vehicle. The Continuation Vehicle provides Loftware with dedicated capital to support future growth. The transaction also provides RS2 Healthcare Partners with additional committed funding to pursue new platform investments.

RS2 Healthcare Partners originally acquired Loftware in 2014. Over the course of the investment, the Firm has supported the Company’s transformation from a US-focused labeling provider into the leading independent global platform offering mission-critical software and applications enabling its customers to design, deliver and trace labels across complex supply chains with significant regulatory and compliance requirements. During this period, Loftware completed four strategic add-on acquisitions that expanded its products and capabilities to establish an end-to-end, highly-integrated solution serving global supply chains. Loftware generates approximately $125 million in revenue and serves more than 10,000 customers across over 100 countries.

AKKR has been an investor in Loftware since March 2023, when the Firm sold a partial stake in the Company to AKKR. The Continuation Vehicle deepens this existing partnership and delivers meaningful benefits to all stakeholders. The transaction offered existing limited partners the options to maintain their existing investments or to receive liquidity or roll over their interests into the Continuation Vehicle with new unfunded capital commitments to support the Company’s growth plans.

Atlantic-Pacific Capital, Inc. served as exclusive financial advisor and placement agent, and Choate Hall & Stewart LLP served as legal counsel to RS2 Healthcare Partners.

About RS2 Healthcare Partners

Founded in 1989, RS2 Healthcare Partners (formerly Riverside Partners) is a Boston-based private equity firm with total capital commitments of $1.6 billion raised since inception. The Firm exclusively focuses on healthcare investing in the lower middle market. RS2 Healthcare Partners combines a disciplined investment strategy, specialized sector expertise, a highly experienced team of investment professionals and healthcare advisors, and a collaborative approach to partnering with founders and management teams. For more information, visit www.rs2healthcare.com.

About Loftware

Loftware is the global leader in product identification. Loftware’s cloud-based solutions power real-time collaboration, ensure compliance, improve authenticity, and deliver supply chain traceability from product development to consumer engagement. Loftware provides scalable, data-driven labeling and packaging technologies that help companies boost speed to market, enhance efficiency, and connect physical products to digital experiences. Trusted by global brands and backed by over 40 years of innovation, Loftware supports customers across industries with offices in the United States, United Kingdom, Slovenia, China, and Singapore. For more information, visit www.loftware.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/riverside-partners-rebrands-as-rs2-healthcare-partners-closes-continuation-vehicle-for-loftware-302768290.html

SOURCE Riverside Partners

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Honoring Dr. J. Craig Venter’s Legacy, Human Longevity Launches Clinical-Grade $599 Whole Genome Sequencing Report with AI-Enhanced Insights for Proactive Disease Prevention

Published

on

By

SOUTH SAN FRANCISCO, Calif., May 11, 2026 /PRNewswire/ — Human Longevity, Inc. today announced the launch of its new Clinical-Grade $599 Whole Genome Sequencing Report, designed to bring advanced genomic medicine and AI-driven disease prevention to the general population.

Despite major advances in medicine, most diseases today are still identified only after symptoms appear — often limiting opportunities for earlier intervention and prevention. While genomic sequencing has generated vast amounts of biological data, one of healthcare’s biggest challenges has been translating that data into actionable health insights at scale.

Human Longevity’s new offering honors the legacy of Dr. J. Craig Venter, whose pioneering work helped decode the first human genome and transform modern medicine.

More than two decades ago, the Human Genome Project required over $3 billion and years of international effort to decode a single human genome. Today, Human Longevity is making a clinical grade genome sequencing broadly accessible with a comprehensive AI-enhanced genomic insight platform for just $599.

Dr. Venter long predicted that the human genome would play an increasingly important role in managing individual health and preventing disease. In recent years, a growing body of global scientific research has continued to validate this vision, demonstrating that genomics is becoming a foundational tool for predicting disease risk, guiding prevention strategies, and enabling more personalized healthcare.

“Dr. Venter believed that genomics would fundamentally transform medicine from reactive sick care to a proactive healthcare model,” said Wei-Wu He, Ph.D. Executive Chairman of Human Longevity Inc. “A decade ago, he founded Human Longevity to combine whole genome sequencing with advanced imaging, including Whole Body MRI, multi-omics data, longitudinal health data and AI, to help people live longer, healthier lives. We are proud to continue that mission by democratizing access to decades of work led by Human Longevity.”

Over the last decade, Human Longevity has invested more than $600 million building one of the world’s most comprehensive longitudinal health datasets. The company has collected and analyzed data from more than 10,000 individuals over a 10-year period, enabling the development of proprietary AI-driven insights focused on major age-related chronic diseases such as cardiovascular disease, cancer, and dementia.

The new Clinical-Grade Whole Genome Sequencing Insight Report is designed to provide individuals with actionable insights into inherited disease risks, carrier status, pharmacogenomics, longevity-associated traits, and personalized disease prevention opportunities.

“Our vision is simple,” added Dr. He. “Every individual should have access to their genome and AI-powered health insights. The genome is the foundation of modern preventive medicine.”

The new service will be available nationwide immediately through Human Longevity’s website.

For more information, visit:

Human Longevity Website

About Human Longevity, Inc.

Founded in 2013, Human Longevity, Inc. is a biotechnology company at the forefront of integrating genomics, artificial intelligence, and multimodal diagnostics to extend human healthspan founded by genomics pioneer J. Craig Venter. HLI delivers comprehensive, data-driven evaluations designed to identify and mitigate disease risk long before symptoms arise. The company is committed to redefining healthcare through AI-driven proactive diagnostics and personalized preventive care.

To learn more, visit http://www.humanlongevity.com/.

Media Contact:
media@humanlongevity.com
www.humanlongevity.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/honoring-dr-j-craig-venters-legacy-human-longevity-launches-clinical-grade-599-whole-genome-sequencing-report-with-ai-enhanced-insights-for-proactive-disease-prevention-302768424.html

SOURCE Human Longevity, Inc.

Continue Reading

Technology

DocuPet Launches AnimalsFirst Integration to Increase Pet Protection Nationwide

Published

on

By

SYRACUSE, N.Y., May 11, 2026 /PRNewswire/ — DocuPet is proud to announce a new strategic partnership with AnimalsFirst, marking the official launch of an integrated solution designed to connect animal welfare organizations directly with DocuPet’s National Pet Registry. This collaboration represents a significant milestone in DocuPet’s long-term vision to streamline shelter operations while expanding pet registration across North America.

For several years, DocuPet has invested in building a flexible, scalable software infrastructure capable of supporting integrations with leading shelter management systems. With the continued growth of the National Pet Registry and the National Animal Shelter Network (NASN), DocuPet is now positioned to activate these capabilities AnimalsFirst offers a highly customizable shelter management platform that supports adoptions, foster coordination, medical tracking, and field services for approximately 120 animal welfare organizations. Through this partnership, shelter partners using AnimalsFirst will be able to directly register adopters and their pets into the National Pet Registry through a streamlined backend integration.

Expanding Protection Through the National Pet Registry

At the core of this partnership is a shared commitment to increasing the number of pets enrolled in DocuPet’s National Pet Registry. Registration is a critical step in protecting pets, ensuring that accurate, up-to-date ownership information is readily accessible when a lost animal is found.

DocuPet’s HomeSafe® service plays a vital role in this effort. Each registered pet receives a free tag with a unique code linked to its secure online profile. When a lost pet is found, anyone can use the information on the tag to quickly initiate the reunification process. This immediate connection dramatically improves return-to-home rates and reduces the time pets spend in shelters.

Getting visible identification tags on pets is one of the simplest yet most effective ways to keep animals safe, and the success is multiplied when using DocuPet tags that offer superior reunification benefits. By increasing registration at the point of adoption and throughout the community, DocuPet and its partners are helping ensure more pets have the protection they need.

“We are thrilled to partner with AnimalsFirst and to be able to offer our registration program to shelters and pet owners utilizing their platform,” said Jackie Rose, CSO of DocuPet. “This enhanced and streamlined process will allow pet owners to easily register to receive the protection benefits of having a free pet identification tag, connected to our 24/7 lost pet recovery system.” 

Strengthening the Animal Welfare Ecosystem

This integration supports a broader, interconnected animal welfare ecosystem that includes pet owners, shelters, and animal control agencies. For pet owners, it provides peace of mind and an easy way to safeguard their animals. For shelters, it helps reduce overcrowding and administrative burden by increasing successful reunifications. For animal control officers, it offers a fast, reliable method to identify and return lost pets in the field.

By embedding registration opportunities directly into shelter workflows, DocuPet and AnimalsFirst are helping create a more proactive, efficient system; one that prioritizes prevention, accelerates reunification, and ultimately improves outcomes for animals and the communities that care for them.

This partnership underscores DocuPet’s commitment to leveraging technology to support animal welfare organizations, reduce administrative burden, and ensure more pets are protected through reliable identification and recovery services.

About DocuPet
DocuPet is the largest and fastest-growing pet registration and reunification platform in North America, providing official pet licensing services to more than 300 jurisdictions. DocuPet provides free lost pet services through HomeSafe®, and a unique product offering with an AI-powered pet tracker, designer pet tags, and other pet products/services. DocuPet is transforming how communities support animal welfare through inventive thinking and pioneering technology.

About AnimalsFirst
AnimalsFirst is a customizable shelter management software platform designed to support the operational needs of animal welfare organizations, including adoption management, foster coordination, medical tracking, and field services.

For more information, visit https://partnerships.docupet.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/docupet-launches-animalsfirst-integration-to-increase-pet-protection-nationwide-302767346.html

SOURCE DocuPet

Continue Reading

Technology

Boundary Labs Announces $2M Pre-Seed Led by Galaxy Ventures to Launch Verifiable Institutional Stablecoin, USBD

Published

on

By

The current stablecoin landscape often forces institutions to rely on trust in opaque centralized models, off-chain systems, and reserves. Boundary is solving this by introducing a protocol where verifiability is the core product feature.

NEW YORK, May 11, 2026 /PRNewswire/ — Boundary today announced the closing of a $2M USD pre-seed funding round led by Galaxy Ventures. Joining the round are a cohort of leading institutional finance partners and angels, including VCs BlackWood and FirstBlock Capital. The capital will accelerate the launch of USBD, a novel stablecoin protocol engineered specifically for financial and blockchain institutions and approved participants who require a new standard of on-chain verifiability in the >$300B stablecoin market.

“Trust but verify” is a phrase core to the on-chain industry as it champions a critical principle where institutions and retail should not just trust but also verify that what a protocol says and offers is real. Without real verifiable, there is no real trust. This is paramount to the industry’s security, stability, and scalability. However, the current stablecoin landscape often forces institutions to rely on trust rather than working with immediately verifiable products and reserves.

Boundary is solving this by introducing a protocol where verifiability is the core product feature. By providing institutional counterparties with clear technical documentation and a framework for verifiability of reserves and stablecoin performance, Boundary allows institutions to move on-chain with the certainty required for large-scale institutional stablecoin use cases like treasury management, regulated wrappers, and on-chain collateral.

The Boundary Protocol introduces a sophisticated structure designed for institutional compliance and operational clarity:

On-chain Verifiability: Unlike first generation stablecoins, USBD is built for continuous auditability of financial fundamentals, providing institutions with the data-driven confidence needed for professional participation and fiduciary products.Institutional-Only Onboarding: Access will be facilitated through a dedicated dApp designed for rigorous KYC and KYB workflows, ensuring only qualifying institutional participants enter the ecosystem in the institutional growth phase.Strategic Ecosystem Support: As a participant in several institutional partnerships, soon to be announced, and having completed a security audit by Cyfrin, Boundary has quickly positioned itself as the project with the leading technology to ensure protocol integrity.

“Boundary represents a proposition that speaks the language of institutional finance,” said Matthew Mezger, Co-Founder of Boundary. “By prioritizing verifiability and partnering with Galaxy Ventures, we are providing the professional-grade infrastructure necessary to reach our initial milestone of $100M in Total Value Locked (TVL) in 2026”.

Following today’s announcement, and building on a successful proof-of-concept for the protocol’s self-funding capability through derisked decentralized market participation, Boundary will initiate a Private Placement Campaign to onboard initial institutional partners.

“Institutional adoption of stablecoins is not only well underway but already proving its value in real-world use cases. With a long runway of growth still ahead, unlocking the full potential of stablecoins requires infrastructure that is not just secure, but inherently verifiable,” said Danny Slutsky, Investor at Galaxy Ventures. “Boundary’s focus on professional participants and its goal to bridge the gap between traditional finance and blockchain makes it a promising player in growing the stablecoin market.”

About Boundary: Boundary Labs is mandated by the Boundary Foundation and Boundary OpCo to lead the design, development, and commercial representation of the Boundary project. Based in New York City, the firm provides financial institutions and professional participants with secure, verifiable access to the USBD stablecoin and the broader Boundary Protocol ecosystem. For more information, visit https://boundary.finance/.

View original content to download multimedia:https://www.prnewswire.com/news-releases/boundary-labs-announces-2m-pre-seed-led-by-galaxy-ventures-to-launch-verifiable-institutional-stablecoin-usbd-302767720.html

SOURCE Boundary Labs International, Inc.

Continue Reading

Trending